Skip to main content

Table 1 Coverage and timeliness of vaccines in the South African EPI program.

From: Vaccination coverage and timeliness in three South African areas: a prospective study

 

Site

Coverage

(end of follow-up)

Timely vaccination

Given too early

Given too late

Not given

(at end of follow-up)

Polio 0

Paarl

99 (96-100)

99 (96-100)

0 (0-0)

0 (0-0)

1 (0-4)

 

Umlazi

100 (98-100)

99 (97-100)

0 (0-0)

1 (0-1)

0 (0-2)

 

Rietvlei

99 (96-100)

94 (91-97)

0 (0-0)

4 (3-6)

1 (0-4)

 

Total

100 (99-100)

97 (96-98)

0 (0-0)

3 (2-3)

0 (0-1)

BCG vaccine

Paarl

99 (97-100)

99 (97-100)

0 (0-0)

0 (0-0)

1 (0-3)

 

Umlazi

100 (98-100)

100 (98-100)

0 (0-0)

0 (0-0)

0 (0-2)

 

Rietvlei

99 (97-100)

99 (97-100)

0 (0-0)

0 (0-0)

1 (0-3)

 

Total

99 (98-100)

99 (98-100)

0 (0-0)

0 (0-0)

1 (0-2)

Polio 1

Paarl

100 (98-100)

92 (90-93)

1 (0-2)

7 (5-8)

0 (0-2)

 

Umlazi

99 (98-100)

88 (86-89)

1 (0-3)

10 (8-12)

1 (0-2)

 

Rietvlei

96 (92-98)

72 (67-75)

1 (0-4)

22 (19-25)

4 (2-8)

 

Total

99 (98-99)

85 (84-87)

1 (1-2)

12 (11-14)

1 (1-2)

DPT1+Hib+HBV

Paarl

100 (98-100)

93 (90-94)

0 (0-2)

6 (4-8)

0 (0-2)

 

Umlazi

99 (98-100)

88 (86-89)

1 (1-3)

10 (8-12)

1 (0-2)

 

Rietvlei

97 (95-99)

77 (73-79)

2 (1-4)

19 (16-21)

3 (1-5)

 

Total

99 (98-100)

87 (85-88)

1 (1-2)

11 (10-12)

1 (0-2)

Polio 2

Paarl

99 (97-100)

94 (92-94)

1 (0-2)

4 (3-5)

1 (0-3)

 

Umlazi

98 (96-99)

90 (87-91)

0 (0-2)

8 (6-9)

2 (1-4)

 

Rietvlei

87 (82-91)

72 (67-75)

1 (0-3)

14 (12-14)

13 (9-18)

 

Total

96 (94-97)

87 (85-88)

1 (0-1)

8 (7-9)

4 (3-6)

DPT2+Hib+HBV

Paarl

99 (97-100)

95 (93-95)

0 (0-2)

3 (2-4)

1 (0-3)

 

Umlazi

98 (96-99)

90 (88-91)

0 (0-2)

7 (6-8)

2 (1-4)

 

Rietvlei

92 (88-95)

80 (75-82)

0 (0-3)

12 (10-13)

8 (5-12)

 

Total

97 (96-98)

90 (88-91)

0 (0-1)

7 (6-8)

3 (2-4)

Polio 3

Paarl

94 (91-96)

93 (91-94)

1 (0-3)

0 (0-0)

6 (4-9)

 

Umlazi

98 (96-99)

87 (83-88)

0 (0-2)

11 (9-13)

2 (1-4)

 

Rietvlei

69 (62-75)

64 (57-71)

0 (0-0)

5 (4-5)

31 (25-38)

 

Total

87 (85-89)

84 (82-86)

0 (0-1)

2 (2-3)

13 (11-15)

DPT3+Hib+HBV

Paarl

94 (91-96)

92 (90-93)

1 (0-3)

0 (0-0)

6 (4-9)

 

Umlazi

90 (87-93)

86 (83-88)

0 (0-2)

4 (3-4)

10 (7-13)

 

Rietvlei

74 (68-80)

70 (64-73)

0 (0-3)

4 (4-4)

26 (20-32)

 

Total

88 (86-90)

85 (83-86)

1 (0-1)

3 (3-3)

12 (10-14)

  1. Coverage at end of follow-up and the proportion receiving the vaccinations within the recommended time periods (timely vaccination) are presented with 95% confidence intervals. Similarly, untimely vaccination are categorised into vaccines given earlier or later than recommended. Rates given for each of the three sites and in total
  2. * The pentavalent vaccine (DPT1+Hib+HBV) protects against diphtheria, pertussis, tetanus, Haemophilus influenzae type b and hepatitis B